Overview
Product name | Recombinant Human NKG2C/KLRC2/CD159c Protein |
---|
Catalog No. | RP02743 |
---|
Description | Recombinant Human NKG2C/KLRC2/CD159c Protein is produced by Expi293 cells expression system. The target protein is expressed with sequence (Glu98-Leu231) of Human NKG2C (Accession #P26717) fused with His tag and Avi tag at the N-terminus. |
---|
Purity | > 95% as determined by Tris-Bis PAGE |
---|
Endotoxin | Less than 1EU per μg by the LAL method. |
---|
Species | Human |
---|
Calculated MW | 15.3 kDa |
---|
Background
As a first line of defense, natural killer (NK) cells play a crucial role in the fight against infections.The presented study is the first of its kind that ascribes CD56dimCD16 NKG2C-expressing NK cells a crucial role in biasing adaptive immune responses upon influenza vaccination and suggests NKG2C as a potential biomarker in predicting pandemic influenza vaccine responsiveness.
Product information
Synonym | CD159c; KLRC2; NKG2C; NK cell receptor C |
---|
Expression Host | HEK293 cells |
---|
Tag | N-His&Avi |
---|
Swiss-Prot | |
---|
Gene ID | |
---|
Usage guide
Storage | Store at -20℃.Store the lyophilized protein at -20℃ to -80 ℃ up to 1 year from the date of receipt. After reconstitution, the protein solution is stable at -20℃ for 3 months, at 2-8℃ for up to 1 week. |
---|
Reconstitution | Centrifuge the tube before opening. Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. Avoid vortex or vigorously pipetting the protein. For long term storage, it is recommended to add a carrier protein or stablizer (e.g. 0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose), and aliquot the reconstituted protein solution to minimize free-thaw cycles. |
---|
* For research use only. Not for therapeutic or diagnostic purposes.